The GLP-1 landscape
The GLP-1 medication category has been dominated by injectable options since the first approvals. Oral formulations are newer and the landscape is evolving rapidly.
Formulation overview
GLP-1 pill vs injection
Understanding your oral and injectable options. Most GLP-1 medications are weekly injections, but oral options are expanding. Here is a broad overview of how oral and injectable GLP-1 formulations compare across convenience, clinical data, and available medications.
- Compared
- Oral tablets · Weekly and daily injections
- Sources
- FDA labels and approvals, published trials
Currently approved oral GLP-1s
- Wegovy® pill (oral semaglutide 25mg) — FDA-approved December 2025 for chronic weight management. The first oral GLP-1 approved for weight loss.
- Rybelsus® (oral semaglutide 7mg/14mg) — FDA-approved 2019 for type 2 diabetes. Not approved for weight management.
Currently approved injectable GLP-1s
- Wegovy® injection (semaglutide 2.4mg) — Weekly, weight management
- Ozempic® (semaglutide) — Weekly, type 2 diabetes
- Zepbound® (tirzepatide) — Weekly, weight management
- Mounjaro® (tirzepatide) — Weekly, type 2 diabetes
- Saxenda® (liraglutide) — Daily, weight management
Oral vs injectable at a glance
General differences between oral and injectable GLP-1 formulations.
| Feature | Oral (pill) | Injectable |
|---|---|---|
| Administration | Daily pill taken by mouth | Weekly injection (subcutaneous) |
| Frequency | Once daily | Once weekly (most options) |
| Needles required | No | Yes (pre-filled pen) |
| Fasting required | Yes — 30 min before food/drink | No dietary restrictions |
| Storage | Room temperature | Refrigerated (most options) |
| Clinical data maturity | Newer (expanding) | Years of published data |
| Currently available | Wegovy pill, Rybelsus | Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda |
Practical considerations
Each formulation has practical trade-offs to discuss with your healthcare provider.
Oral GLP-1
Potential advantages
- No needles or injection site management
- No refrigeration required — easier to store and travel with
- May be preferred by patients with needle aversion
- Wegovy pill launched at a lower starting price point
Considerations
- Daily dosing required (vs weekly for most injectables)
- Must take on an empty stomach with 30-minute fasting window
- Newer formulations with less long-term published data
- Fewer oral options currently available
Injectable GLP-1
Potential advantages
- Weekly dosing for most options (Ozempic, Wegovy, Mounjaro, Zepbound)
- No fasting or dietary restrictions around dosing
- Extensive clinical trial data spanning years
- More medication options to choose from
Considerations
- Requires subcutaneous injection (needles)
- Most require refrigeration between 36-46 degrees F
- Injection site rotation and management needed
- Less convenient for travel
What's coming next
The landscape of oral GLP-1 options is expanding. Here are notable developments in the pipeline.
Orforglipron (Eli Lilly)
Orforglipron is a non-peptide oral GLP-1 receptor agonist being developed by Eli Lilly. Unlike current oral GLP-1 pills that require special absorption-enhancing formulations and fasting, orforglipron is a small molecule that may not require the same dietary restrictions. It is currently under FDA review based on the ATTAIN clinical trial program. If approved, it would represent a new class of oral GLP-1 medication.
Wegovy® HD (Novo Nordisk)
Novo Nordisk's higher-dose injectable semaglutide (7.2mg, branded as Wegovy HD) was approved in March 2026. While this is an injectable, it reflects the broader trend of expanding GLP-1 options across both formulations.
The trend toward oral
Multiple pharmaceutical companies are developing oral GLP-1 formulations. The industry is trending toward more oral options, which could significantly expand access by removing the injection barrier for many patients.
Looking for the Wegovy®-specific comparison?
For a detailed comparison of the Wegovy pill versus the Wegovy injection specifically, including OASIS 4 trial data, dosing schedules, and switching guidance, see our dedicated page: Wegovy pill vs injection.
Track any GLP-1 medication, free.
Pill or injection, Dose AI tracks your doses, symptoms, weight, and nutrition in one place.
4.7 · 994 App Store ratings · 55,000+ downloads · Featured by Apple
Questions people ask
Is there a pill version of GLP-1 for weight loss?
Yes. The Wegovy pill (oral semaglutide 25mg) was FDA-approved in December 2025 for chronic weight management. It is the first oral GLP-1 medication specifically approved for weight loss. Rybelsus (oral semaglutide) is approved for type 2 diabetes but not weight management.
Is the GLP-1 pill as effective as the injection?
Clinical trials suggest comparable results for some oral and injectable GLP-1 formulations, but each was studied in separate trials with different populations and designs. Direct comparison across trials is not reliable. Consult your healthcare provider about which option may be appropriate for you.
Why do GLP-1 pills need to be taken on an empty stomach?
Oral GLP-1 medications use special absorption-enhancing formulations to survive stomach acid and be absorbed through the stomach lining. Food in the stomach can interfere with this absorption process, which is why patients must fast for at least 30 minutes after taking the pill.
What is orforglipron?
Orforglipron is an oral non-peptide GLP-1 receptor agonist being developed by Eli Lilly. Unlike current oral GLP-1 pills that require fasting, orforglipron is a small molecule that may not have the same dietary restrictions. It is currently under FDA review based on the ATTAIN clinical trial program.
Does Dose AI track both oral and injectable GLP-1 medications?
Yes. Dose AI tracks any GLP-1 medication regardless of formulation. Whether you take a daily pill or weekly injection, the app helps you log doses, track symptoms, monitor weight, and manage your nutrition.
Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before making any decisions about your health or medications.